Low cd8 t cell counts predict benefit from hypoxia-modifying therapy in muscle-invasive bladder cancer

HIGHLIGHTS

• who: Vicky Smith and collaborators from the Division of Sciences, University of Manchester, Manchester , PL, UK have published the article: Low CD8 T Cell Counts Predict Benefit from Hypoxia-Modifying Therapy in Muscle-Invasive Bladder Cancer, in the Journal: Cancers 2022, 41 of 11/Nov/2022
• what: The work is important for the design of a future biomarker-driven trial where MIBC patients with high CD8 T_cells could be randomised to receive standard-of-care treatment with or without an ICI; patients with low CD8 T_cells would receive radiotherapy plus CON. The primary objective in . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.